Zenith Epigenetics Announces Clinical Trial Collaboration with Pfizer
20 nov. 2018 08h30 HE
|
Zenith Capital Corp.
Collaboration to evaluate ZEN-3694 in combination with Talazoparib in TNBC patients; Phase 1b/2 trial expected to initiate 1Q 2019 CALGARY, Alberta, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Zenith...
Zenith Epigenetics Announces Publication of Covalent Bromodomain Inhibitors, Offering a Novel Approach to Targeting BET Bromodomains
01 oct. 2018 08h30 HE
|
Zenith Capital Corp.
CALGARY, Alberta, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Zenith Epigenetics Ltd. (“Zenith” or the “Company”), a wholly-owned subsidiary of Zenith Capital Corp., announced today the publication of a...
Zenith Announces Voting Results from the 2018 Annual Meeting of Shareholders
12 sept. 2018 18h00 HE
|
Zenith Capital Corp.
CALGARY, Alberta, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Zenith Capital Corp. ("Zenith" or the "Company") announces that, at its annual meeting of shareholders held earlier today, Zenith shareholders...
Zenith Epigenetics Announces Publication of a Case Study From its Ongoing mCRPC Clinical Study
04 sept. 2018 08h00 HE
|
Zenith Capital Corp.
CALGARY, Alberta, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Zenith Epigenetics Ltd. (“Zenith” or the “Company”), a wholly-owned subsidiary of Zenith Capital Corp., announced today the publication of a...
Zenith Capital Closes $5.7 Million Private Placement
31 août 2018 18h00 HE
|
Zenith Capital Corp.
This press release is not for dissemination in the United States or through US newswire services CALGARY, Alberta, Aug. 31, 2018 (GLOBE NEWSWIRE) -- Zenith Capital Corp. ("Zenith" or the "Company")...
Zenith Announces Further Advancement of Clinical Trial with ZEN-3694, a Proposed Equity Offering and an Update Webcast
04 juin 2018 07h00 HE
|
Zenith Capital Corp.
CALGARY, Alberta, June 04, 2018 (GLOBE NEWSWIRE) -- Zenith Capital Corp. ("Zenith" or the "Company") today announced that its wholly owned subsidiary, Zenith Epigenetics Ltd. ("Zenith Epigenetics"),...
Zenith Announces Webcast Presentation at the BIO Investor Forum in San Francisco, CA
16 oct. 2017 14h17 HE
|
Zenith Capital Corp.
CALGARY, Alberta, Oct. 16, 2017 (GLOBE NEWSWIRE) -- Zenith Capital Corp. (“Zenith” or the “Company”) today announces its participation in the upcoming BIO Investor Forum in San Francisco, CA. Mr....
Zenith Announces Annual General Meeting of Shareholders
02 oct. 2017 18h21 HE
|
Zenith Capital Corp.
CALGARY, Alberta, Oct. 02, 2017 (GLOBE NEWSWIRE) -- Zenith Capital Corp. (“Zenith” or the “Company”) announced today that its Annual Meeting of Shareholders (the “Meeting”) is to be held Tuesday,...